Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
about
Stepping down asthma treatment: how and whenDiagnostic approach in cases with suspected work-related asthmaAnti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenInhaled steroids for acute asthma following emergency department dischargeAnti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenAddition of anti-leukotriene agents to inhaled corticosteroids for chronic asthmaIdentification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysisCough: are children really different to adults?Immunological and inflammatory assessmentsEosinophilic bioactivities in severe asthmaYear in review 2015: Asthma and chronic obstructive pulmonary diseaseBenralizumab: a unique IL-5 inhibitor for severe asthmaEosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary diseaseClinical asthma phenotypes in the real world: opportunities and challengesApproach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), IranTargeted anti-inflammatory therapeutics in asthma and chronic obstructive lung diseaseResearch in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK)Emerging therapies for severe asthmaMultidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense?Toll-like receptor ligands LPS and poly (I:C) exacerbate airway hyperresponsiveness in a model of airway allergy in mice, independently of inflammationPharmacological strategies to reduce exacerbation risk in COPD: a narrative reviewSevere asthma: anti-IgE or anti-IL-5?Management of the patient with eosinophilic asthma: a new era beginsBiomarkers in the Management of Difficult AsthmaFeNO and asthma treatment in children: a systematic review and meta-analysisElevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthmaK(Ca)3.1 channel-blockade attenuates airway pathophysiology in a sheep model of chronic asthmaClinical profile of patients with adult-onset eosinophilic asthmaSOCS3 silencing attenuates eosinophil functions in asthma patientsHow variability in clinical phenotypes should guide research into disease mechanisms in asthmaReslizumab for Poorly Controlled, Eosinophilic AsthmaThe relationship between eosinophilia and airway remodelling in mild asthmaIdentification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program.Predicting intermediate phenotypes in asthma using bronchoalveolar lavage-derived cytokines.Can asthma control be improved by understanding the patient's perspective?Data-driven asthma endotypes defined from blood biomarker and gene expression data.Assessing airway inflammation in clinical practice - experience with spontaneous sputum analysis.Sputum proteomics in inflammatory and suppurative respiratory diseasesMetabolomic biomarkers in a model of asthma exacerbation: urine nuclear magnetic resonance.Identification and management of adults with asthma prone to exacerbations: can we do better?
P2860
Q23916999-4CECD76C-7A96-4E98-8A23-A1FA65F9DF41Q23922950-EA9D48BF-9174-4739-B4E3-FB733E476358Q24197682-C2686099-CD79-456B-A47B-EB48B67E4FCFQ24202560-D7895914-B62B-472B-AD06-E7ABC494F87DQ24247433-728D025B-972E-481D-B51D-21722061B551Q24247489-2B5F4143-8E73-4415-8811-142FFAD35C06Q24658537-2140CFF3-9C72-4B51-A9E7-B6BF19B20E61Q24813220-C718701A-541C-4F10-9DD9-8297D22A6100Q24995755-A142BAF1-B7AA-4943-BF8F-00EBFD7EAFF6Q26744175-BBC656EA-5DEC-4AD8-8298-3B7B92382BF0Q26749314-4BA11D68-E90B-4F6D-A747-AEEFD0DE3261Q26750711-9B739652-48B5-4402-A8D4-44893226C19EQ26771819-962BF2D7-3772-40DF-A2A6-B461A00A0A5EQ26775236-EE0FE3B3-3ED5-4460-8B10-DC2E32AE2FFDQ26777154-5749C7D6-1E95-4191-90CF-30E5D9517D8BQ26786229-ABF9404C-612D-4BD4-844B-5B2A9A67B433Q26800021-3EE7C673-A678-42C2-926B-756A7584F090Q26861260-1CE4D1A0-9C6A-4B9D-9F3F-E09EB8FC9C30Q27025554-9B273B17-CC6F-4627-9570-BE21C6FCEBF4Q27316569-C4694588-3A68-4E40-95DE-36105FDA9D16Q28070274-A38ADCAD-5187-415A-9E4E-E584BEF25726Q28071832-012AAC6C-B766-4D60-A3E0-A0410349C106Q28078191-AF3E36E1-0310-4CD2-8621-9394ABAE8523Q28081109-59FAACBD-0A65-4FF4-B22C-C2001AAF4692Q28081734-89FB66D9-4E92-404C-B9FA-A7D941E195A6Q28390947-AE98AE79-13E7-4E24-BB1F-5BFEAD64AE53Q28534242-F5F2456D-561A-475C-B8FD-CCE2622C9787Q28596640-753DF93A-5232-438F-8298-A80B436CC870Q28649788-2BE710F4-71B9-4C8D-8033-55E5DCC40C1AQ28657369-31B172DB-D418-4DDC-8C1A-444E6878A60FQ29040017-EFF97892-67FB-4303-9543-6FEF17810420Q30409216-D73111C6-2AF8-4A0E-B232-92AAC73942BAQ30433207-6749B7AE-C48F-4491-BA1A-EC788B32EA94Q30433497-3F5C91C4-1E12-4360-A5EF-FCB96B759307Q30831813-3CE61E45-4E6D-432F-9B84-967CF9DEE370Q30887089-C8384627-14F5-47D6-A951-EF5FDEDDCBE9Q33321687-DBE3031A-DE93-4221-B6BE-969022340836Q33345110-AFD07F56-4B59-4ED4-9FBC-28079D0C8135Q33377897-C21ECAEC-AC29-4FBD-A3B8-731FAE4E3208Q33396567-10313E4D-9022-4901-928D-37013336C209
P2860
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
@en
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
@nl
type
label
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
@en
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
@nl
prefLabel
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
@en
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
@nl
P2093
P50
P1433
P1476
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial
@en
P2093
Beverley Hargadon
Debbie Parker
Ruth H Green
Susan McKenna
P304
P356
10.1016/S0140-6736(02)11679-5
P407
P577
2002-11-01T00:00:00Z